Kudo M - Search Results

1

Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial.

Cainap C, Qin S, Huang WT, Chung IJ, Pan H, Cheng Y, Kudo M, Kang YK, Chen PJ, Toh HC, Gorbunova V, Eskens FA, Qian J, McKee MD, Ricker JL, Carlson DM, El-Nowiem S. Cainap C, et al. Among authors: kudo m. J Clin Oncol. 2015 Jan 10;33(2):172-9. doi: 10.1200/JCO.2013.54.3298. Epub 2014 Dec 8. J Clin Oncol. 2015. PMID: 25488963 Free PMC article. Clinical Trial.

2

Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score.

Chung H, Kudo M, Takahashi S, Hagiwara S, Sakaguchi Y, Inoue T, Minami Y, Ueshima K, Fukunaga T, Matsunaga T. Chung H, et al. Among authors: kudo m. J Gastroenterol Hepatol. 2008 Mar;23(3):445-52. doi: 10.1111/j.1440-1746.2007.05075.x. Epub 2007 Aug 6. J Gastroenterol Hepatol. 2008. PMID: 17683486

3

Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.

Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S. Takahashi S, et al. Among authors: kudo m. Oncology. 2007;72 Suppl 1:98-103. doi: 10.1159/000111714. Epub 2007 Dec 13. Oncology. 2007. PMID: 18087189

4

Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study.

Kudo M, Sakaguchi Y, Chung H, Hatanaka K, Hagiwara S, Ishikawa E, Takahashi S, Kitai S, Inoue T, Minami Y, Ueshima K. Kudo M, et al. Oncology. 2007;72 Suppl 1:132-8. doi: 10.1159/000111719. Epub 2007 Dec 13. Oncology. 2007. PMID: 18087194

5

Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma.

Taniguchi M, Kim SR, Imoto S, Ikawa H, Ando K, Mita K, Fuki S, Sasase N, Matsuoka T, Kudo M, Hayashi Y. Taniguchi M, et al. Among authors: kudo m. World J Gastroenterol. 2008 Apr 7;14(13):1997-2002. doi: 10.3748/wjg.14.1997. World J Gastroenterol. 2008. PMID: 18395898 Free PMC article. Clinical Trial.

6

Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.

Kudo M. Kudo M. Oncology. 2008;75 Suppl 1:1-12. doi: 10.1159/000181865. Epub 2008 Dec 17. Oncology. 2008. PMID: 19092266 Review.

7

Combination therapy with S-1 and pegylated interferon alpha for advanced hepatocellular carcinoma.

Ueshima K, Kudo M, Nagai T, Tatsumi C, Ueda T, Takahashi S, Hatanaka K, Kitai S, Ishikawa E, Inoue T, Hagiwara S, Minami Y, Chung H. Ueshima K, et al. Among authors: kudo m. Oncology. 2008;75 Suppl 1:106-13. doi: 10.1159/000173431. Epub 2008 Dec 17. Oncology. 2008. PMID: 19092279

8

Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice.

Kudo M. Kudo M. Int J Clin Oncol. 2010 Jun;15(3):242-55. doi: 10.1007/s10147-010-0089-y. Epub 2010 May 28. Int J Clin Oncol. 2010. PMID: 20509038 Review.

9

Management of hepatocellular carcinoma: from prevention to molecular targeted therapy.

Kudo M. Kudo M. Oncology. 2010 Jul;78 Suppl 1:1-6. doi: 10.1159/000315222. Epub 2010 Jul 8. Oncology. 2010. PMID: 20616576

10

Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010.

Kudo M. Kudo M. Oncology. 2010 Jul;78 Suppl 1:113-24. doi: 10.1159/000315239. Epub 2010 Jul 8. Oncology. 2010. PMID: 20616593 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,554 results

Search Page

Filters